Measurement of Blood Volume Loss During Burn Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-31

Study Completion Date

2021-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Burn surgery is associated with significant reductions in hematocrit. However, it is unclear whether these reductions are the result of hemodilution from non-red cell containing intraoperative transfusions or from loss of red blood cells. The investigators will be using the Daxor Blood Volume Analyzer (BVA-100), an FDA approved instrument that can measure total blood volume, plasma volume, and RBC volume using the indicator dilution technique. By comparing pre-operative measurements of blood volume, plasma volume, and RBC volume to that of post-operative measurements after burn surgery, the investigators can determine the primary cause of the reduction in hematocrit associated with burn surgery. The investigators hypothesize that these reductions in hematocrit are primarily the result of hemodilution rather than blood loss and that there will be a statistically significant difference in measured plasma volume from the pre-operative group to the post-operative group.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery

NCT00660608

Coronary Artery Disease

COMPLETED

Transcutaneous-Arterial Carbon Dioxide and Microcirculatory Dysfunction

NCT02328846

Bypass Complications

WITHDRAWN

Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.

NCT03249038

Blood Loss, Surgical Blood Loss Blood Loss, Postoperative

COMPLETED

Blood Volume and Fluid Kinetics in Patients Undergoing Extracorporal Circulation

NCT01115166

Blood Volume, Extravasation

COMPLETED

Endothelial Dysfunction As A Predictor Of Perioperative Outcome

NCT00384683

Endothelial Dysfunction

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Burn surgery is associated with significant changes (reductions) in hematocrit. However, it is unclear whether these reductions are the result of hemodilution from non-red cell containing intraoperative transfusions or from loss of red blood cells. The investigators will be using the Daxor Blood Volume Analyzer (BVA-100), an FDA approved instrument that can measure total blood volume, plasma volume, and RBC volume using the indicator dilution technique. With this technique, a tracer substance (I-131 albumin) is mixed with an unknown volume. An identical amount of the tracer is mixed into a solution with a known volume. By comparing the concentration of the indicator between the known and unknown volumes, the investigators can determine the volume of the unknown volume (or in this case, the blood volume).

The investigators will be measuring the change in blood volume, plasma volume, and RBC volume from the pre-operative to the post-operative state after completion of burn surgery. We hypothesize that these reductions in hematocrit are primarily the result of hemodilution rather than blood loss and that there will be a statistically significant change in measured plasma volume from the pre-operative to the post-operative measurements.

Average plasma volume for male and female patients is 2950ml SD=590 ml. To detect a 10% increase in plasma volume from hemodilution with a power 0.80 and alpha error 0.05, a one tailed normal distribution t-test determines a sample size fifty. To account for a 10% data loss (technical difficulty, patient withdraw) a sample size of fifty-five would be required.

Fifty-five consecutive adult patients (18 years or older) having burn surgery will be enrolled. Patients with recognized coagulopathy will be excluded. The outcome variables included blood volume (BV, ml), plasma volume (PV, ml) and red blood cell volume (RBCV, ml). All three outcome variables will be measured at two time points; pre-surgery and post-surgery. The pre-surgery measurement will be collected precisely after induction of general anesthesia but prior to surgery start. The post-surgery measurement will be taken immediately after the operation and after all intraoperative red blood cell transfusions are complete. For those patients receiving blood transfusions in the operating room prior to all data collection points, the transfused RBC volume will be recorded and subtracted from the RBCV measured after the transfusion. Transfused RBCV will take into account Hct of 60% for pRBCs. Additional baseline information, including age (year), sex (male, female), weight (kg), and surgery type, will be collected. For the tracer dilution method, the following blood samples will be collected: a baseline (no radiation sample), a first sample 12 minutes after injection (after complete mixing in the blood volume) and additional samples every 6 minutes for at least three successive timed sample points. These multiple timed sample points produce a logarithmic curve of radiation over time, as only a small fraction of albumin leaves the blood volume into the interstitial space. The investigators will compare the pre-operative and post-operative blood volume, RBC volume, and plasma volume measurements to determine if the decrease in hematocrit associated with burn surgery is truly due to hemodilution or loss of RBC volume.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Blood Loss Burns

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pre-operative cohort

This cohort will have their total blood volume, RBC volume, and plasma volumes measured using the Daxor BVA-100 prior to any surgical intervention

Measurement of RBC volume, plasma volume, and total blood volume using Daxor BVA-100

Intervention Type DIAGNOSTIC_TEST

Measurement of RBC volume, plasma volume, and total blood volume using Daxor BVA-100

Post-operative cohort

This cohort will consist of the same study participants in the pre-operative cohort. The only difference is that this cohort will have their total blood volume, RBC volume, and plasma volumes measured using the Daxor BVA-100 AFTER burn surgery.

Burn surgery

Intervention Type PROCEDURE

Burn surgery including wound debridement, skin grafting

Measurement of RBC volume, plasma volume, and total blood volume using Daxor BVA-100

Intervention Type DIAGNOSTIC_TEST

Measurement of RBC volume, plasma volume, and total blood volume using Daxor BVA-100

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Burn surgery

Burn surgery including wound debridement, skin grafting

Intervention Type PROCEDURE

Measurement of RBC volume, plasma volume, and total blood volume using Daxor BVA-100

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Sustained thermal burn of a depth that is deep partial thickness to full thickness and requires operative management
* Burn excision must occur within one week of thermal injury
* Burn size between 10-50% of total body surface area
* Must survive initial resuscitation
* Must consent for blood product transfusion
* Male or non-pregnant female

Exclusion Criteria

* Cause of burn other than thermal injury (ie electrical or chemical injury)
* Women who are nursing, pregnant, or think they may be pregnant
* Patients with recognized coagulopathy

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes